Atul Ltd Q4 PAT up 23.93% at Rs175cr on sharp growth in the life sciences chemicals vertical

Date:05-13-2021

Atul Ltd reported 15.58% yoy growth in consolidated sales revenues for the Mar-21 quarter at Rs1,115.93cr. Among the two major verticals of Atul, the Life Sciences chemicals business grew by 23% at Rs312cr while the performance chemicals grew by 9.7% at Rs818cr. Revenues were higher by 17.11% on a sequential basis compared to Dec-20 quarter.

The consolidated Profit after tax (PAT) for the Mar-21 quarter was up 23.93 at Rs175cr. While the higher revenues did help, the company also witnessed a sharp spike of 21.6% in the cost of materials consumed due to a mix of higher input prices and supply chain constraints.

The net profit margins improved from 14.63% in the Mar-20 quarter to 15.69% in the Mar-21 quarter. On a sequential basis, the profits were down -7.2% as the sharply higher input costs took its toll in the current Mar-21 quarter. As a result, even the net margins were lower compared to 19.79% net margins in the Dec-20 quarter.

Financial highlights for Mar-21 compared yoy and sequentially